NDA Filing Slowdown Continues; FDA Has Received 16 NMEs In FY 2002
FDA has received only 16 NDA submissions for new molecular entities thus far in fiscal 2002
FDA has received only 16 NDA submissions for new molecular entities thus far in fiscal 2002